Vaccitech makes short move to new headquarters; EnteroBiotix raises more than $21M in Series A
Oxford biotech Vaccitech is moving headquarters — but only about 20 minutes away.
Vaccitech signed a lease for 31,000 square feet within the Zeus development at Harwell Science and Innovation Campus. The firm plans to relocate its headquarters there next spring from its current headquarters in Oxford. The length of the lease was not disclosed.
The company’s operations will be taking about half the space in that building, according to a Vaccitech statement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.